SMART ART 研究
南非 ART 分娩可扩展干预的序贯多重分配随机试验:SMART ART 研究
The investigators propose A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa- the SMART ART study-a randomized study to test adaptive ART delivery for persons with detectable viral load and/or not engaged in care.The types of differentiated service delivery (DSD) that will be examined in this study are incentives, community-based ART, and home delivery. The study plans to enroll up to 900 participants-people living with HIV and who are eligible for ART and living in KwaZulu-Natal, South Africa. The study aims to maximize the proportion of ART eligible persons living with HIV who achieve viral suppression at 18 months. The study will also evaluate the preferences of clients and providers for differentiated service delivery, and evaluate the cost effectiveness of adaptive HIV treatment for those who are not engaged in care.
研究概览
地位
详细说明
Of the 8 million people in South Africa living with HIV, only 56% are on antiretroviral therapy (ART), and 45% are virally suppressed, substantially below the UNAIDS goal of 73%. Detectable viral load results in HIV-associated morbidity and mortality, and HIV transmission. Patient barriers to care, such as missed wages, transport costs, and long wait times for clinic visits and ART refills, are associated with detectable viral load. HIV differentiated service delivery (DSD) has simplified ART delivery: incentives, multi-month scripts, fast-track ART, and community or home ART delivery motivate clients, reduce the frequency of clinic visits, and decongest clinics. DSD is standard for clients who achieve viral suppression and engage in care; however, DSD needs adaptation to serve clients who are not succeeding. Indeed, persons who are not engaged in care arguably need simplified, client-centered approaches even more than those who can successfully engage.
A suite of adaptive DSD strategies, including incentives strategies, community-based ART, and home delivery, have been tested among stable clients with viral suppression. Lottery incentives effectively change short-term behavior, increasing ART initiation.Community-based and home ART delivery increase ART coverage and simplify ART access overcoming clinic barriers11. For stable clients, these DSD activities are as effective as clinic-based care in terms of achieving and maintaining viral suppression, although among stable clients they have not shown superiority in viral suppression or cost savings. In contrast, DSD has the potential to improve rates of viral suppression and retention in care and save costs among persons not engaged in care. There is great potential that DSD systems can be client-responsive and system-efficient for subgroups requiring additional services, matching services with client needs. A sequential, comprehensive package of DSD approaches, with each step increasing the intensity of service provision - adaptive DSD - has not been tested to determine the proportion and characteristics of persons who would achieve viral suppression and retention in care and to estimate the cost-effectiveness and budget impact.
To increase population level viral suppression, persons with detectable viral load need responsive DSD interventions. A Sequential Multiple Assignment Randomized Trial (SMART) design facilitates evaluation of a stepped, adaptive approach to achieving viral suppression with 'right-sized' interventions. The investigators are an experienced team and propose to build on the strong partnerships to sequentially test adaptive DSD strategies for persons with detectable viral load and/or not engaged in care: incentives, community-based ART, and home delivery. As the Center for Community Based Research, the investigators maintain strong connections with stakeholders including department of health, traditional leaders and ward counsellors throughout the Greater Edendale Area (GEA) and the Vulindlela sub-district of the uMgungundlovu District Municipality. Due to the size of the recruitment target, this work will centre around the Caluza clinic but will extend into other parts of GEA and sub-district of Vulindlela over the course of recruitment. The aim is to identify the most effective and efficient HIV care delivery strategies.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
KwaZulu-Natal
-
Sweetwaters、KwaZulu-Natal、南非
- Human Sciences Research Council Sweetwaters
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Must be 18 years or older
- Able and willing to provide informed consent for study procedures
- Must self report that they will reside in the study community for the duration of follow-up
- Living with HIV and eligible for ART by national guidelines, have a detectable viral load greater than the lower limit of detection and/or not engaged in care, and are stable clinically (CD4>100 cells, no moderate/severe screening laboratory abnormalities for kidney function i.e. eGFR >50 mL/min/1.73m2, not receiving treatment for active tuberculosis or other opportunistic infections).
Exclusion Criteria:
- There are no separate exclusion criteria.
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:顺序分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预:Best clinic practices
Participants start with best clinic practices and continue for 18 months (including participants who are non-responders at month 6 and are randomized to stay in their original arm) |
|
|
实验性的:Best clinic practices plus lottery incentives
Participants start with best clinic practices plus lottery incentives and continue for 18 months (including participants who are non-responders at month 6 and are randomized to stay in the original arm) |
Conditional lottery incentives Welcome back service (friendly providers, SMS, adherence support) Fast-track ART |
|
实验性的:Randomized from best clinic practices to smart lockers
Second randomization into community ART through the use of smart lockers |
Decentralized ART refills and monitoring, adherence support Continue with best clinic practices |
|
实验性的:Randomized from best clinic practices to home delivery
Second randomization into home ART delivery |
Continue with best clinic practices Home ART refill and monitoring, adherence support |
|
实验性的:Randomized from best clinic practices plus lottery incentives to smart lockers
Second randomization into community ART through the use of smart lockers |
Conditional lottery incentives Welcome back service (friendly providers, SMS, adherence support) Fast-track ART Decentralized ART refills and monitoring, adherence support |
|
实验性的:Randomized from best clinic practices plus lottery incentives to home delivery
Second randomization into home ART delivery |
Conditional lottery incentives Welcome back service (friendly providers, SMS, adherence support) Fast-track ART Home ART refill and monitoring, adherence support |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Viral suppression at 18 months
大体时间:18 months
|
The primary outcome is viral suppression at 18 months among the combined group of persons living with HIV who have detectable viral load and persons not engaged in care at enrollment. |
18 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Retention in Care
大体时间:12 months
|
The proportion of clinical visits and medication refills missed over the last 12 months of the intervention |
12 months
|
|
Time to ART initiation
大体时间:6 months
|
Time to antiretroviral therapy initiation |
6 months
|
|
Engagement in care
大体时间:18 months
|
Proportion of people who are virally suppressed in each intervention arm |
18 months
|
|
Comparison to viral suppression and retention outcomes from similar local clinics
大体时间:18 months
|
Proportion of individuals who are virally suppressed who are engaged in care in intervention arms compared to local clinics |
18 months
|
合作者和调查者
调查人员
- 首席研究员:Ruanne V Barnabas, DPhil、University of Washington
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2022P001129
- R01MH124465 (美国 NIH 拨款/合同)
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.